Analyzing HLA-G polymorphisms in children from women with scleroderma

Area of Science:

• Immunogenetics
• Reproductive Immunology
• Autoimmune Diseases

Background:

• Soluble human leukocyte antigen-G (sHLA-G) is vital for immune tolerance in pregnancy and transplantation.
• Women with systemic sclerosis (SSc) exhibit higher fetal microchimerism (Mc) post-pregnancy.
• Fetal microchimerism involves the presence of fetal cells/DNA in the maternal body.

Purpose of the Study:

• To investigate if children of women with SSc possess a high sHLA-G secretor profile, hypothesized to explain increased fetal microchimerism.
• To analyze HLA-G polymorphisms in children born to mothers with SSc compared to healthy mothers.

Main Methods:

• Evaluated 16 HLA-G polymorphisms using a three-step multiplex PCR SNaPshot method.
• Analyzed DNA samples from first-born children of 39 women with SSc and 32 healthy women.
• Focused on specific HLA-G variations in the 3' untranslated region and 5' Upstream Regulatory Region.

Main Results:

• Contrary to the hypothesis, children from mothers with SSc did not exhibit a high sHLA-G profile.
• The study observed the opposite trend, with lower sHLA-G levels in children of women with SSc.
• No significant difference in HLA-G polymorphisms was found between the two groups.

Conclusions:

• The findings challenge the initial hypothesis linking high fetal microchimerism in SSc to a high fetal sHLA-G profile.
• Suggests alternative mechanisms may underlie the increased fetal microchimerism observed in women with SSc.
• Highlights the need for further research into the role of HLA-G in scleroderma pathogenesis and pregnancy outcomes.